BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17663972)

  • 21. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K; Corash L; Bhargava V
    Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism.
    Gregersen H; Nørgaard M; Severinsen MT; Engebjerg MC; Jensen P; Sørensen HT
    Eur J Haematol; 2011 Feb; 86(2):129-34. PubMed ID: 20942842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome.
    Grimaldi D; Bartolucci P; Gouault-Heilmann M; Martin-Toutain I; Khellaf M; Godeau B
    Thromb Haemost; 2008 Apr; 99(4):782-3. PubMed ID: 18392339
    [No Abstract]   [Full Text] [Related]  

  • 24. Splenic tuberculosis associated with monoclonal gammopathy of undetermined significance and pericarditis.
    Cheung WI; Leung VK; Luk IS; Loke TK; Chan JC; Chau TN
    Hong Kong Med J; 2009 Aug; 15(4):291-3. PubMed ID: 19652238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveal effusion associated with an IgM lambda subtype monoclonal gammopathy.
    Khaouly S; Vilaplana D
    Arch Soc Esp Oftalmol; 2014 Sep; 89(9):382-6. PubMed ID: 24370379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waldenström's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance.
    Iwanaga M; Yoshida Y; Tagawa M; Sekine I; Kamihira S; Tomonaga M
    Leuk Res; 2009 Jan; 33(1):193-5. PubMed ID: 18455789
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
    Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic thrombocytopenic purpura and monoclonal gammopathy of undetermined significance accompanied by urinary bladder carcinoma.
    Kaneko Y; Murakami H; Matsushima T; Tamura J; Sawamura M; Karasawa M; Naruse T; Tsuchiya J
    Clin Exp Rheumatol; 1993; 11(2):217. PubMed ID: 8508567
    [No Abstract]   [Full Text] [Related]  

  • 30. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in malignant transformation of monoclonal gammopathy of undetermined significance.
    Adami F; Bortolin M; Lestani M; Chilosi M; Semenzato G
    Leuk Lymphoma; 2002 Aug; 43(8):1713-4. PubMed ID: 12400621
    [No Abstract]   [Full Text] [Related]  

  • 32. [Two cases of orbital myositis with monoclonal gammopathy of undetermined significance].
    Nakazawa T; Yamaguchi K; Nakagawa Y; Suzuki K; Takahashi H; Tamai M
    Nippon Ganka Gakkai Zasshi; 2004 Feb; 108(2):110-7. PubMed ID: 15022434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraproteinemic neuropathies.
    Rojas-García R; Gallardo E; Illa I
    Presse Med; 2013 Jun; 42(6 Pt 2):e225-34. PubMed ID: 23618626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal gammopathy of undetermined significance: new insights.
    Chen BH
    CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV infection masquerading as monoclonal gammopathy of undetermined significance.
    Lu CM; Dezube BJ; Pantanowitz L
    N Engl J Med; 2003 Sep; 349(12):1192-3. PubMed ID: 13679540
    [No Abstract]   [Full Text] [Related]  

  • 36. Angioimmunoblastic lymphadenopathy with dysproteinemia. Immunohistologic and ultrastructural studies.
    Valdes AJ; Blair OM
    Am J Clin Pathol; 1976 Sep; 66(3):551-9. PubMed ID: 1085561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of monoclonal gammopathy].
    Huijgens PC; Zweegman S
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1401-2. PubMed ID: 12174432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal gammopathy and neuropathy.
    Ramchandren S; Lewis RA
    Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple myeloma with Sweet disease developing from monoclonal gammopathy of undetermined significance and Sjögren syndrome].
    Harada Y; Egi Y; Honda Y; Shirota T; Hayashi T
    Rinsho Ketsueki; 2001 Dec; 42(12):1176-80. PubMed ID: 11828720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.